Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.
SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
---|---|---|---|---|
AARTI DRUGS | 586.15 0.48% | 584.90 -0.28% | More Info ![]() |
|
AJANTA PHARMA | 953.10 -1.53% | 954.10 -1.42% | More Info ![]() |
|
ALEMBIC PHARMA | 538.60 -1.57% | 539.55 -0.90% | More Info ![]() |
|
BIOCON LTD | 615.85 1.48% | 616.15 1.70% | More Info ![]() |
|
CADILA HEALTHCARE | 312.35 0.26% | 311.90 0.03% | More Info ![]() |
|
CIPLA | 539.20 -0.40% | 539.65 -0.28% | More Info ![]() |
|
DIVIS LABORATORIES | 1,588.50 0.88% | 1,587.85 0.83% | More Info ![]() |
|
GLENMARK PHARMA | 579.00 0.45% | 579.15 0.36% | More Info ![]() |
|
INDOCO REMEDIES | 176.40 1.41% | 174.95 1.07% | More Info ![]() |
|
IPCA LABS | 800.55 -1.10% | 804.85 -0.42% | More Info ![]() |
|
J.B.CHEMICALS | 320.20 2.28% | 321.05 2.13% | More Info ![]() |
|
LUPIN LTD | 763.25 -1.02% | 763.10 -1.01% | More Info ![]() |
|
NATCO PHARMA | 570.35 -0.56% | 569.80 -0.93% | More Info ![]() |
|
NIFTY 50 | Not Listed | 10,604.35 -0.34% | More Info ![]() |
|
ORCHID PHARMA LTD | 3.24 0.62% | 18.90 -2.83% | More Info ![]() |
|
PANACEA BIOTECH | 160.55 0.91% | 161.75 0.68% | More Info ![]() |
|
PIRAMAL ENTERPRISES | 2,173.05 0.18% | 2,179.60 0.13% | More Info ![]() |
|
S&P BSE SENSEX | 35,352.61 -0.41% | Not Listed | More Info ![]() |
|
STRIDES PHARMA SCIENCE | 402.90 -1.20% | 404.10 -1.04% | More Info ![]() |
|
SUN PHARMA | 414.35 -0.18% | 413.65 -0.24% | More Info ![]() |
|
TORRENT PHARMA | 1,765.15 0.35% | 1,763.35 -0.01% | More Info ![]() |
|
WOCKHARDT LTD. | 392.25 0.51% | 392.15 0.65% | More Info ![]() |
BSE prices: February 19, 2019 (Close) NSE prices: February 19, 2019 (Close)
The NIFTY PHARMA Index was at 8,543.6 (down 0.4%). The index is down 17.1% over the last 30 days. And over the last 1 year, it has lost 9.1%.
Within the Indian Pharma sector, the top gainers were J.B.CHEMICALS (up 2.3%) and BIOCON LTD (up 1.5%). On the other hand, ALEMBIC PHARMA (down 1.6%) and AJANTA PHARMA (down 1.5%) were among the top losers.
Meanwhile, the benchmark NIFTY 50 was at 10,604.4 (down 0.3%).
| |
Indian share markets witnessed selling pressure during closing hours and ended their trading session marginally lower.Sectoral indices ended on a mixed note with realty stocks.
For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.
For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.
Here's an analysis of the annual report of DIVIS LABORATORIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.
Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.
Price erosion in generic US drugs continues but seems to be bottoming out.
More Views on NewsManagements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...
The real estate sector is ready to make a comeback. This is the stock to consider buying.
This is the trick to following super investors and not losing money.
Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.
During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.
More
| |